HOUSTON, March 11, 2021 /PRNewswire/ -- Soliton,
Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary platform technology, today
announced members of management will be presenting at three
upcoming healthcare conferences.
Event:
|
33rd Annual Virtual
ROTH Conference
|
Format:
|
Presentation &
1x1 Meetings
|
Date:
|
March 15 – 17,
2021
|
Presentation:
|
Presentation will be
available on-demand beginning on Monday, March 15, 2021 at 9am
ET
|
Location:
|
Webcast
Link
|
|
|
Event:
|
Oppenheimer 31st
Annual Healthcare Conference
|
Format:
|
Presentation &
1x1 Meetings
|
Date:
|
Tuesday, March 16,
2021
|
Time:
|
4:30pm – 5:00pm
ET
|
Location:
|
Webcast
Link
|
|
|
Event:
|
Maxim 2021 Emerging
Growth Virtual Conference
|
Format:
|
Presentation
|
Date:
|
March 17 – 18,
2021
|
Presentation:
|
Presentation will be
available on-demand beginning on Wednesday, March 17, 2021 at 9:00
a.m. ET
|
Location:
|
Investors can
register for the conference here
|
Audio webcasts of Soliton's presentations will be available on
the investor relations section of Soliton's website at
https://ir.soliton.com/. Replays of the webcasts will be available
for 90 days after the date of the presentation.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer
Center. The Company's first FDA cleared commercial product,
RESONIC™, will use rapid pulses of acoustic shockwaves as an
accessory to lasers for the removal of unwanted tattoos and the
treatment of cellulite. The Company is based in Houston, Texas, and is actively engaged in
bringing RESONIC to the market. The Company believes this "Soliton"
method has the potential to lower tattoo removal costs for
patients, while increasing profitability to practitioners, compared
to current laser removal methods. The Company also believes the
technology will provide the first non-invasive acoustic technology
to target the underlying causes of dimples and ridges in cellulite.
Soliton is investigating potential additional capabilities of the
RAP technology. The device is currently cleared in the United States only for use in tattoo
removal and cellulite.
For more information about the Company, please
visit: http://www.soliton.com
Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, Section
21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995, which statements involve
risks and uncertainties. These statements relate to future events,
future expectations, plans and prospects. Although Soliton believes
that the expectations reflected in such forward-looking statements
are reasonable as of the date made, actual results or outcomes may
prove to be materially different from the expectations expressed or
implied by such forward-looking statements. Soliton has attempted
to identify forward-looking statements by terminology including
''believes,'' ''estimates,'' ''anticipates,'' ''expects,''
''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,''
''could,'' ''might,'' ''will,'' "would," ''should,''
''approximately'' or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are only predictions and involve known and unknown
risks, uncertainties, and other factors, including those discussed
in our filings with the Securities and Exchange Commission ("SEC"),
including under the heading " Risk Factors" in our most recently
filed Form 10-K filed with the SEC and as updated in our Form 10-Q
filings and in our other filings with the SEC. Any
forward-looking statements contained in this release speak only as
of its date. Soliton undertakes no obligation to update any
forward-looking statements contained in this release to reflect
events or circumstances occurring after its date or to reflect the
occurrence of unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-to-participate-in-three-upcoming-healthcare-conferences-301244907.html
SOURCE Soliton, Inc.